MTOR and breast carcinoma: The PI3K-protein kinase B (AKT)-mammalian target of rapamycin (mTOR) cascade is one of the major downstream signaling pathways in human cells (Fruman et al., 2017), and its deregulation has been implicated in breast cancer development and progression (Lee et al., 2015).